Research and Markets: Market for Molecular Biology Products Is Contracting in Major European Countries
Posted on: Tuesday, 10 May 2005, 09:00 CDT
DUBLIN, Ireland, May 10 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c17153 ) has announced the addition of European Customer Market Survey - Molecular Biology Products to their offering.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040820/RESEARCH )
The findings of this study suggest that in the major European countries, the market for molecular biology products is contracting. In the UK, single digit growth (8% maximum) is forecasted for the next twelve months. France will have zero growth for the next twelve months. Germany which has in the past been traditionally the largest European market is declining. This economic situation compounded by the fact that there are an excess of suppliers in the market for the bulk of basic molecular biology commodity products means that in the short term price based competition is likely, if not happening already. Longer term, if the economic trend continues, market consolidation by acquisition or exit is predicted. Major Molecular Biology product suppliers such as Sigma and VWR appear are gaining market share in this environment.
A key trend found is that customers, both at the professional purchasing and end user levels are becoming more price sensitive. This is presumably due to the need to maximise spend with limited resources. Price is the main reason for switching suppliers. Customer loyalty to suppliers is centered on a fair price perception coupled to good service provision, particularly product availability and on time delivery.
In an assessment of common molecular biology products for cloning, DNA gel electrophoresis and eukaryotic cell selection, it was found that the majority of end users favour the use of more basic commodity products such restriction enzymes, agarose, standard DNA markers and powdered G418/Geneticin and Hygromycin.
In the majority of cases, there is limited awareness of higher performing cloning technologies. Technical users who are aware perceive little value in these technologies over what they are currently using. More value is seen in products that offer convenience such pre-cast agarose gels, ready made buffers, pre-stained markers, liquid geneticin.
Customer willingness to adopt such offerings would be based on slight premium to same pricing. Revenue opportunities do exist in the market. At the professional purchaser level, most are satisfied with current suppliers. However, if there are improvements in perceived value for money, volume discounts, quality guarantees, customer service and ease of ordering, they will be considered seriously for adoption. At the end user level, customers are willing to switch suppliers for better price deals and will consider bulk purchasing. However the timing of revenue influx needs to be calculated to take into consideration the running down of stocks of previous supplier products and also speed at which new accounts will be adopted. In France the adoption cycle could take up to 6 to 12 months.
The data presented in this report is the result of quantitative opinion derived from 391 individuals involved in the purchase and use of Molecular Biology products in the UK, Germany and France. Opinion was ascertained on two levels, from economic Buyers responsible for purchasing purchase Molecular Biology products and also from technical Buyers, who purchase and use Molecular Biology products.
This report provides intelligence on:
- Current Molecular Biology product suppliers
- Market Share
- Molecular Biology Customer Spending Trends
- Supplier Switching and Why
- Satisfaction and Loyalty
- Willingness for larger quantity ordering
- Adoption barriers
- Barriers to change
- Value perception of commonly used Molecular Biology products
- Value perception of premium Molecular Biology products
- Adoption protocols and Timescales
- Opportunities to enhance Molecular Biology products for suppliers
For more information visit http://www.researchandmarkets.com/reports/c17153
Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040820/RESEARCHAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.com
Research and Markets
CONTACT: Laura Wood, Senior Manager of Research and Markets,press@researchandmarkets.com , or fax, +353-1-4100-980
Web site: http://www.researchandmarkets.com/reports/c17153
Source: PRNewswire
Related Articles
- China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS
- China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
- China Biologic Products Enters Into International Market With its First Sales Order from India
- Nanogen and Thermo Fisher Scientific Partner to Provide Molecular-Biology Products to Research Market
- PTC Helps Customers Bring Better Products To Market Faster Through Work With IBM; PTC(R) Windchill(R) Awarded 'Ready for IBM Rational' Software Validation
- Global Hemophilia Researchers and Caregivers Receive $2.75 Million in Grants From Bayer Biological Products
- Try Market Scan's mPencil Free; Market Scan Customers to Receive a Free 30-Day Trial of the New mPencil Product
- Research and Markets: Decline in European Market for Molecular Biology Products
- Research and Markets: Building Brand Equity in the Molecular Biology Market - Over 1,500 Life Scientists Surveyed
 |
 |
User Comments (0)
RSS Feeds